Microrandomized Trial to Optimize Use of Burden-reducing Self-monitoring Approaches in Behavioral Obesity Treatment

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-70
SponsorThe Miriam Hospital

About this trial

This clinical trial is focused on testing dietary self-monitoring strategies used in behavioral obesity treatment. The goal is to determine which self-monitoring strategies are most useful for whom, at which points in treatment, and under what circumstances.

Researchers will provide a 24-week online behavioral obesity treatment program, and will randomize participants to use one of 5 dietary self-monitoring strategies every two weeks. The five strategies include: recording all food and drink consumed and corresponding energy intake (i.e., "calories") on 7 days per week; recording all food and drink consumed and corresponding energy intake (i.e., "calories") on 3 days per week; self-monitoring of dietary lapses (i.e. any eating/drinking likely to cause weight gain or put weight loss at risk); smartwatch-based monitoring of energy intake (i.e., "calories"); and self-monitoring of body weight only via smart scale.

Participants will:

* Follow a 24-week online program for weight loss and health improvement * Use the assigned self-monitoring strategy every two weeks * Meet with the researchers periodically via online video call and provide research data by answering questions via periodic online surveys.

Eligibility criteria

Qualifiers

English language fluent and literate at the 6th grade level

Body mass index (BMI) above 25 kg/m-squared

Able to walk 2 city blocks without stopping

Not currently participating in another weight loss program

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Online Behavioral Obesity Treatment
  • Full Dietary Self-monitoring
  • Reduced-frequency Dietary Self-monitoring
  • Self-Monitoring of Dietary Lapses Only
  • Smartwatch-based Self-monitoring of Energy Intake
  • Self-monitoring of Body Weight Only

Treatment groups

275 Participants
are divided into 5 treatment groups

Sponsors and collaborators

The Miriam Hospital

Lead sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Collaborator